Investors Sue Viatris Brass For Selling Off Biosimilars
A shareholder has sued Viatris' top brass in Pennsylvania federal court over claims they misled investors by abandoning plans to grow the company's biosimilars business following a merger, sending stock prices...To view the full article, register now.
Already a subscriber? Click here to view full article